MS imaging and absorption methods visualizing sun filter skin spatial distribution and penetration.


Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
07 2022
Historique:
received: 22 09 2021
revised: 07 04 2022
accepted: 25 04 2022
pubmed: 2 5 2022
medline: 29 6 2022
entrez: 1 5 2022
Statut: ppublish

Résumé

Sunscreens must now be effective in protecting skin from ultraviolet, as well as visible/infrared radiation. Here, TriAsorB, a new broad-spectrum sun filter, was formulated with three other sunscreens and their distribution on human skin was studied using a standard penetration protocol and two novel mass spectrometry imaging techniques: atmospheric pressure matrix assisted laser desorption ionization (AP-MALDI) coupled to high resolution mass spectrometry and time of flight - secondary ion mass spectrometry (ToF-SIMS). The standard penetration protocol showed that sun filters absorption was very low, with most of the dose recovered at the surface (none entered the receptor fluid). Absorption was not increased in damaged skin. The results were confirmed by AP-MALDI and ToF-SIMS imaging of the spatial distribution of molecular species in cross-section samples of human skin. Each sun filter was detected on or in the stratum corneum, with a good homogenous coverage over the valleys and peaks of the skin, and correlated well with the distribution of endogenous biomarkers. In conclusion, conventional and novel imaging analysis methods showed that the sun filters remained mainly on the skin surface after topical application. Mass spectrometry imaging is a promising complementary approach to traditional skin penetration studies to visualize penetration of compounds.

Identifiants

pubmed: 35490800
pii: S0168-3659(22)00236-X
doi: 10.1016/j.jconrel.2022.04.040
pii:
doi:

Substances chimiques

Sunscreening Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-88

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

C Jacques (C)

Pierre Fabre Dermo-Cosmétique, Pierre Fabre R&D Center, Applied Research Department, Avenue Hubert Curien, Cedex 01, 31025 Toulouse, France. Electronic address: carine.jacques@pierre-fabre.com.

F Crépel (F)

Pierre Fabre Dermo-Cosmétique, Pierre Fabre R&D Center, Applied Research Department, Avenue Hubert Curien, Cedex 01, 31025 Toulouse, France.

D El Assad (D)

Luxembourg Institute of Science and Technology (LIST), Advanced Characterization Platform, Materials Research and Technology, 41, rue du Brill, L-4422 Belvaux, Luxembourg.

T B Angerer (TB)

Luxembourg Institute of Science and Technology (LIST), Advanced Characterization Platform, Materials Research and Technology, 41, rue du Brill, L-4422 Belvaux, Luxembourg.

J Bour (J)

Luxembourg Institute of Science and Technology (LIST), Advanced Characterization Platform, Materials Research and Technology, 41, rue du Brill, L-4422 Belvaux, Luxembourg.

C Jeanjean-Miquel (C)

Pierre Fabre Dermo-Cosmétique, Pierre Fabre R&D Center, Applied Research Department, Avenue Hubert Curien, Cedex 01, 31025 Toulouse, France.

D Redoules (D)

Laboratoires Avène, Lavaur, France.

D Bacqueville (D)

Pierre Fabre Dermo-Cosmétique, Pierre Fabre R&D Center, Applied Research Department, Avenue Hubert Curien, Cedex 01, 31025 Toulouse, France.

F Pamelard (F)

ImaBiotech SAS, Parc Eurasanté, 885 Avenue Eugène Avinée, 59120 Loos, France.

S Bessou-Touya (S)

Pierre Fabre Dermo-Cosmétique, Pierre Fabre R&D Center, Applied Research Department, Avenue Hubert Curien, Cedex 01, 31025 Toulouse, France.

G Frache (G)

Luxembourg Institute of Science and Technology (LIST), Advanced Characterization Platform, Materials Research and Technology, 41, rue du Brill, L-4422 Belvaux, Luxembourg.

H Duplan (H)

Pierre Fabre Dermo-Cosmétique, Pierre Fabre R&D Center, Applied Research Department, Avenue Hubert Curien, Cedex 01, 31025 Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH